CCR7 ligand delivery and co-delivery in immunotherapy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8592364
APP PUB NO 20110206759A1
SERIAL NO

13025009

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Chemokines may be administered to a patient for immunotolerization. Chemokines include CCL19 and CCL21. Materials and methods for accomplishing tolerization and described.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE (EPFL)EPFL INNOVATION PARK J LAUSANNE CH-1015

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hubbell, Jeffrey A Préverenges, CH 173 9467
Kourtis, Iraklis Larissa, GR 16 133
Shields, Jacqueline D Cumbria, GB 1 49
Swartz, Melody A Préverenges, CH 5 275
Tomei, Alice A Lausanne, CH 2 49

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 26, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00